393 related articles for article (PubMed ID: 31507529)
1. Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis.
Liu XD; Bao Y; Liu GJ
Front Neurol; 2019; 10():934. PubMed ID: 31507529
[No Abstract] [Full Text] [Related]
2. Advanced therapies in Parkinson's disease: Long-term retrospective study.
Merola A; Espay AJ; Romagnolo A; Bernardini A; Rizzi L; Rosso M; Espay KJ; Zibetti M; Lanotte M; Lopiano L
Parkinsonism Relat Disord; 2016 Aug; 29():104-8. PubMed ID: 27215392
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
4. Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation.
Fernández-Rodríguez B; Dupouy J; Harroch E; Fabre-Delcros MH; Barthélémy C; Loubière P; Barange K; Brefel-Courbon C; Rascol O; Ory-Magne F
Rev Neurol (Paris); 2021 Oct; 177(8):919-923. PubMed ID: 34154827
[TBL] [Abstract][Full Text] [Related]
5. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
Tan ZG; Zhou Q; Huang T; Jiang Y
Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
[TBL] [Abstract][Full Text] [Related]
6. Switching and Combining Device-Aided Therapies in Advanced Parkinson's Disease: A Double Centre Retrospective Study.
Georgiev D; Delalić S; Zupančič Križnar N; Socher A; Gurevich T; Trošt M
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326299
[TBL] [Abstract][Full Text] [Related]
7. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
[TBL] [Abstract][Full Text] [Related]
8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
9. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
Wirdefeldt K; Odin P; Nyholm D
CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
[TBL] [Abstract][Full Text] [Related]
10. Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis.
Wang L; Li J; Chen J
Front Neurol; 2018; 9():620. PubMed ID: 30104997
[No Abstract] [Full Text] [Related]
11. Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
Antonini A; Pahwa R; Odin P; Isaacson SH; Merola A; Wang L; Kandukuri PL; Alobaidi A; Yan CH; Bao Y; Zadikoff C; Parra JC; Bergmann L; Chaudhuri KR
CNS Drugs; 2022 Dec; 36(12):1269-1283. PubMed ID: 36414908
[TBL] [Abstract][Full Text] [Related]
12. Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease.
Regidor I; Benita V; Del Álamo de Pedro M; Ley L; Martinez Castrillo JC
Clin Neuropharmacol; 2017; 40(3):103-107. PubMed ID: 28452905
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
14. Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson's disease patients with suboptimal response to deep brain stimulation.
Elkouzi A; Ramirez-Zamora A; Zeilman P; Barabas M; Eisinger RS; Malaty IA; Okun MS; Almeida L
Ann Clin Transl Neurol; 2019 Oct; 6(10):1989-1995. PubMed ID: 31518070
[TBL] [Abstract][Full Text] [Related]
15. Patient preference of device-based treatment of Parkinson's disease.
Aydemir ST; Kumcu MK; Ulukan Ç; Bakirarar B; Akbostancı MC
Int J Neurosci; 2022 Sep; 132(9):925-929. PubMed ID: 33208012
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
Pålhagen SE; Sydow O; Johansson A; Nyholm D; Holmberg B; Widner H; Dizdar N; Linder J; Hauge T; Jansson R; Bergmann L; Kjellander S; Marshall TS
Parkinsonism Relat Disord; 2016 Aug; 29():17-23. PubMed ID: 27318707
[TBL] [Abstract][Full Text] [Related]
17. Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.
Lopiano L; Modugno N; Marano P; Sensi M; Meco G; Solla P; Gusmaroli G; Tamma F; Mancini F; Quatrale R; Zangaglia R; Bentivoglio A; Eleopra R; Gualberti G; Melzi G; Antonini A
J Neurol; 2019 Sep; 266(9):2164-2176. PubMed ID: 31134377
[TBL] [Abstract][Full Text] [Related]
18. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
[TBL] [Abstract][Full Text] [Related]
19. Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review.
Sheshadri V; Rowland NC; Mehta J; Englesakis M; Manninen P; Venkatraghavan L
Can J Neurol Sci; 2017 Nov; 44(6):697-704. PubMed ID: 28920562
[TBL] [Abstract][Full Text] [Related]
20. Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials.
Xu F; Ma W; Huang Y; Qiu Z; Sun L
Neuropsychiatr Dis Treat; 2016; 12():1435-44. PubMed ID: 27382286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]